Some studies have shown that the level of adiponectin in patients with serum NAFLD is significantly lower than that in normal controls, suggesting that the decrease in serum adiponectin may be related to the pathogenesis of NAFLD [10]. The gene discussed is ADIPOQ; the disease is metabolic dysfunction-associated steatotic liver disease.